Companies / Zynerba Pharmaceuticals, Inc.
Zynerba Pharmaceuticals, Inc.
ZYNECIK 1621443
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Sep 13, 2023 | Anido Armando CEO | Sell Open-market sale | Common Stock | $23.6K | -18K -1.87% | 936,722 | low |
| Jan 23, 2023 | Anido Armando CEO | Sell Open-market sale | Common Stock | $21.2K | -35K -5.80% | 576,235 | low |
| Sep 13, 2023 | Sebree Terri B Executive | Sell Open-market sale | Common Stock | $16.4K | -12K -2.04% | 596,241 | low |
| Jan 23, 2023 | Sebree Terri B Executive | Sell Open-market sale | Common Stock | $14.7K | -25K -6.70% | 343,204 | low |
| Jul 19, 2022 | Anido Armando CEO | Sell Open-market sale | Common Stock | $13.1K | -12K -1.91% | 611,688 | low |
| Sep 13, 2023 | Fickenscher James E Executive | Sell Open-market sale | Common Stock | $11.9K | -9K -2.32% | 378,087 | low |
| Jan 23, 2023 | Fickenscher James E Executive | Sell Open-market sale | Common Stock | $10.6K | -18K -10.30% | 154,736 | low |
| Jul 19, 2022 | Sebree Terri B Executive | Sell Open-market sale | Common Stock | $9.1K | -8K -2.20% | 367,865 | low |